Switch to:
GuruFocus has detected 2 Warning Signs with Array BioPharma Inc \$ARRY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Array BioPharma Inc (NAS:ARRY)
Gross Profit
\$140.9 Mil (TTM As of Dec. 2016)

Array BioPharma Inc's gross profit for the three months ended in Dec. 2016 was \$35.5 Mil. Array BioPharma Inc's gross profit for the trailing twelve months (TTM) ended in Dec. 2016 was \$140.9 Mil.

Gross Margin is calculated as gross profit divided by its revenue. Array BioPharma Inc's gross profit for the three months ended in Dec. 2016 was \$35.5 Mil. Array BioPharma Inc's revenue for the three months ended in Dec. 2016 was \$44.5 Mil. Therefore, Array BioPharma Inc's Gross Margin for the quarter that ended in Dec. 2016 was 79.73%.

Array BioPharma Inc had a gross margin of 79.73% for the quarter that ended in Dec. 2016 => Durable competitive advantage

During the past 13 years, the highest Gross Margin of Array BioPharma Inc was 83.20%. The lowest was -9.24%. And the median was 40.00%.

Definition

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Array BioPharma Inc's Gross Profit for the fiscal year that ended in Jun. 2016 is calculated as

 Gross Profit (A: Jun. 2016 ) = Revenue - Cost of Goods Sold = 137.879 - 23.166 = 114.7

Array BioPharma Inc's Gross Profit for the quarter that ended in Dec. 2016 is calculated as

 Gross Profit (Q: Dec. 2016 ) = Revenue - Cost of Goods Sold = 44.523 - 9.026 = 35.5

Array BioPharma Inc Gross Profit for the trailing twelve months (TTM) ended in Dec. 2016 was 37.2 (Mar. 2016 ) + 37.761 (Jun. 2016 ) + 30.426 (Sep. 2016 ) + 35.497 (Dec. 2016 ) = \$140.9 Mil.

Gross Profit is the numerator in the calculation of Gross Margin:

Array BioPharma Inc's Gross Margin for the quarter that ended in Dec. 2016 is calculated as

 Gross Margin (Q: Dec. 2016 ) = Gross Profit (Q: Dec. 2016 ) / Revenue (Q: Dec. 2016 ) = (Revenue - Cost of Goods Sold) / Revenue = 35.5 / 44.523 = 79.73 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Array BioPharma Inc had a gross margin of 79.73% for the quarter that ended in Dec. 2016 => Durable competitive advantage

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Array BioPharma Inc Annual Data

 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Gross_Profit 12.0 7.4 5.1 25.6 43.0 60.9 39.5 -3.9 7.5 114.7

Array BioPharma Inc Quarterly Data

 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Gross_Profit -6.1 13.8 -5.5 5.3 10.0 29.8 37.2 37.8 30.4 35.5
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)